Cashu
Medicenna Therapeutics Corp. Achieves Significant Financial Improvement for FY 2025
2 days ago
Stocks
Health Care
mdna.to
Medicenna Therapeutics Corp
TO: MDNA.TO
+0.02 (+2.41%)
0.85
USD
At close at Jul 01, 24:36 UTC
Overview
Loading chart...
Key Stats
Market Cap
81.34M
Dividend Yield
0.00%
P/E Ratio
NaN
EPS
-0.37
Revenue
-
Avg. Volume
-
About
What does MDNA.TO do?
Medicenna Therapeutics, a Toronto-based immunooncology company with 16 employees, focuses on developing Superkines for cancer treatment and went public on July 13, 2015. Its key products include MDNA11 and bizaxofusp, targeting various cancers.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.